Search

Search Constraints

You searched for: Author/Creator Paoletti, Francesca

Search Results

1. Distinct conformational changes occur within the intrinsically unstructured pro‐domain of pro‐Nerve Growth Factor in the presence of ATP and Mg2+. (26th January 2023)

2. Dynamics of HIV DNA and Residual Viremia in Patients Treated With a Raltegravir-Containing Regimen. (1st February 2015)

3. Dynamics of HIV DNA and Residual Viremia in Patients Treated With a Raltegravir-Containing Regimen. (1st February 2015)

4. Reduced Klebsiella pneumoniae carbapenemase–producing K. pneumoniae (KPC-KP) colonization in a hematological-emergency setting during the coronavirus disease 2019 (COVID-19) pandemic. (11th December 2022)

5. Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study). (January 2014)

6. Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study). (January 2014)

7. Severe rituximab‐induced pneumonitis in an immunocompromised child with acquired thrombotic thrombocytopenic purpura. Issue 2 (6th October 2021)